Full name
QUADRO PHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
10.89 - Manufacture of other food products not elsewhere classified
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.39.Z - Non-specialised wholesale of food, beverages and tobacco
46.46 - Wholesale of pharmaceutical goods
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -67,9 | -5,7 | 43,6 | 869,5 |
EBITDA | -67 | -5,1 | 43,6 | 951,4 |
Short time liabilities | 14,2 | 5,2 | 1,1 | -79,4 |
Equity capital | -98,1 | -103,7 | -60,2 | 42 |
Operating profit (EBIT) | -67 | -5,1 | 43,6 | 951,4 |
Assets | 66,1 | 51,4 | 90,9 | 76,6 |
Net profit (loss) | -67,9 | -5,7 | 43,6 | 869,5 |
Cash | 18,7 | 6,5 | 49,1 | 652,6 |
Net income from sale | 68,9 | 106,5 | 111,1 | 4,3 |
Liabilities and provisions for liabilities | 164,2 | 155,2 | 151,1 | -2,7 |
Working assets | 66,1 | 51,4 | 90,9 | 76,6 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 69,3 | 5,5 | -72,4 | -77,9 |
Equity capital to total assets | -148,3 | -201,7 | -66,2 | 135,5 |
Gross profit margin | -98,5 | -5,3 | 39,2 | 44,5 |
EBITDA Margin | -97,2 | -4,8 | 39,2 | 44 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 75 | 18 | 4 | -14 |
Current financial liquidity indicator | 4.651032447814941 | 9.911925315856934 | 85.11134338378906 | 75,2 |
Net dept to EBITDA | -1.9584919214248657 | -28.039649963378906 | 2.3148255348205566 | 30,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane